Nacuity Pharmaceuticals, Inc. clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

1. Notable

   SLORP Preserve · 24-Month Trial of NPI-001 for the Preservation…SLORP Preserve · 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

   Recruitment opened

   Also in this update: Primary and study completion pushed from Feb 2029 to Apr 2029

   Nacuity Pharmaceuticals, Inc.·Phase 3· NCT07710196· Registry history of NCT07710196 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.